120 related articles for article (PubMed ID: 22489912)
1. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
Mannino DM; Valvi D; Mullerova H; Tal-Singer R
COPD; 2012 Aug; 9(4):359-66. PubMed ID: 22489912
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.
Valvi D; Mannino DM; Müllerova H; Tal-Singer R
Int J Chron Obstruct Pulmon Dis; 2012; 7():173-82. PubMed ID: 22419864
[TBL] [Abstract][Full Text] [Related]
3. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.
Mannino DM; Homa DM; Akinbami LJ; Ford ES; Redd SC
MMWR Surveill Summ; 2002 Aug; 51(6):1-16. PubMed ID: 12198919
[TBL] [Abstract][Full Text] [Related]
5. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey.
Yang Q; Liu T; Kuklina EV; Flanders WD; Hong Y; Gillespie C; Chang MH; Gwinn M; Dowling N; Khoury MJ; Hu FB
Arch Intern Med; 2011 Jul; 171(13):1183-91. PubMed ID: 21747015
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.
Mannino DM; Davis KJ; Kiri VA
Respir Med; 2009 Feb; 103(2):224-9. PubMed ID: 18945605
[TBL] [Abstract][Full Text] [Related]
7. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.
Ekberg-Aronsson M; Pehrsson K; Nilsson JA; Nilsson PM; Löfdahl CG
Respir Res; 2005 Aug; 6(1):98. PubMed ID: 16120227
[TBL] [Abstract][Full Text] [Related]
8. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.
Mannino DM; Homa DM; Akinbami LJ; Ford ES; Redd SC
Respir Care; 2002 Oct; 47(10):1184-99. PubMed ID: 12354338
[TBL] [Abstract][Full Text] [Related]
9. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
10. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.
Lindberg A; Lundbäck B
Clin Respir J; 2008 Oct; 2 Suppl 1():64-71. PubMed ID: 20298352
[TBL] [Abstract][Full Text] [Related]
11. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
12. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
Tantucci C; Donati P; Nicosia F; Bertella E; Redolfi S; De Vecchi M; Corda L; Grassi V; Zulli R
Respir Med; 2008 Apr; 102(4):613-9. PubMed ID: 18083020
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
[TBL] [Abstract][Full Text] [Related]
14. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002.
Wildman RP; Muntner P; Chen J; Sutton-Tyrrell K; He J
Am J Cardiol; 2005 Dec; 96(11):1579-83. PubMed ID: 16310445
[TBL] [Abstract][Full Text] [Related]
15. Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA.
Ohrlander T; Dencker M; Acosta S
Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):43-7. PubMed ID: 22051733
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
[TBL] [Abstract][Full Text] [Related]
17. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.
Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW
Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286
[TBL] [Abstract][Full Text] [Related]
18. Calprotectin--a marker of mortality in COPD? Results from a prospective cohort study.
Holmgaard DB; Mygind LH; Titlestad I; Madsen H; Pedersen SS; Mortensen OH; Pedersen C
COPD; 2013 Oct; 10(5):581-7. PubMed ID: 23844942
[TBL] [Abstract][Full Text] [Related]
19. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
20. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
